Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers
The Food and Drug Administration announced it will require manufacturers of over-the-counter (OTC) pain relievers, fever reducers and cough and cold medications that contain acetaminophen (the active ingredient in Tylenol and many other brands) to revise their labeling to include warnings about potential safety risks, such as liver damage, associated with the use of these popular drugs. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149573.htm
Learn More

FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers
The Food and Drug Administration announced it will require manufacturers of over-the-counter (OTC) pain relievers, fever reducers and other cough and cold medication that contain aspirin (the active ingredient in Bayer Aspirin and many other brands) to revise their labeling to include warnings about potential safety risks, such as internal bleeding, associated with the use of these popular drugs. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm149573.htm
Learn More

Date Published Title Drug Source
2009-04-30 FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers Acetaminophen FDA
2009-04-30 FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers Aspirin FDA
2009-04-30 FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers Ibuprofen FDA
2009-04-30 FDA Requires Additional Labeling for Over-the-Counter Pain Relievers and Fever Reducers Naproxen FDA
2009-04-30 New Guide for Using Methadone Safely Methadone FDA
2009-04-10 Recall of Seroquel XR (quetiapine fumarate) 50mg Samples Quetiapine Manufacturer
2009-04-10 National Recall of Pharmaceutical Associates, Inc. Brand Cimetidine Oral Solution Cimetidine Manufacturer
2009-04-09 Withdrawal of Raptiva (efalizumab) From the U.S. Market Efalizumab Manufacturer
2009-04-01 National Recall on Caraco Brand Digoxin Digoxin Manufacturer
2009-04-01 FDA Warns Companies to Stop Producing Unapproved Narcotics Morphine FDA
2009-04-01 FDA Warns Companies to Stop Producing Unapproved Narcotics Oxycodone FDA
2009-04-01 FDA Warns Companies to Stop Producing Unapproved Narcotics Dilaudid FDA
2009-03-24 Recall on Single Lot of Propafenone 225 mg Tablets Propafenone FDA
2009-03-20 Insulin Pens and Insulin Cartridges Must Not Be Shared Insulin FDA
2009-03-20 Insulin Pens and Insulin Cartridges Must Not Be Shared Insulin Aspart FDA
2009-03-20 Insulin Pens and Insulin Cartridges Must Not Be Shared Insulin Glargine FDA
2009-03-20 Insulin Pens and Insulin Cartridges Must Not Be Shared Insulin Lispro FDA
2009-03-20 Several lots of DAYTRANA (methylphenidate transdermal system) Voluntarily Recalled Methylphenidate Manufacturer
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Testosterone FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Clonidine FDA
Back to Consumer Med Safety